emjreviews.com1d
Achieving Low Disease Activity in Lupus Reduces Organ Damage and Flare Risk
Study reveals that achieving low disease activity or remission in lupus patients with high disease activity reduces organ ...
Too Old to Operate21h
Dapirolizumab Pegol Reduces SLE Activity & Corticosteroid Use
CD40L inhibitor dapirolizumab pegol significantly reduced disease activity and corticosteroid use in patients with SLE in the PHOENYCS GO trial.
Lupus Foundation of America4d
Fate Therapeutics Announces Promising Initial Data from FT819 Phase 1 Study for Moderate to Severe Systemic Lupus Erythematosus
Fate Therapeutics has announced encouraging initial data from the FT819 phase 1 autoimmunity study for people with ...
Daily8d
Cutaneous systemic lupus associated with increased risk for ASCVD, reveals research
Researchers have established that an association exists between cutaneous lupus erythematosus (CLE) and an increased risk for ...
rheumatologyadvisor3d
Nearly One-Fourth of Patients With SLE Face Delays in Accessing Specialized Care
A considerable percentage of patients with SLE experienced delayed access to specialized care, which was associated with organ damage accrual.
Lupus Foundation of America12d
Altered Brain Connectivity Linked to Cognitive Impairments in People with Systemic Lupus Erythematosus
A new study published in Lupus Science & Medicine investigated the relationship between homotopic connectivity, which refers ...